HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: A 2-year study

Mycoses

Volumn 41, Issue 7-8, 1998, Pages 321-325

  Hoegl, L ^a,b   Thoma Greber, E ^a   Rocken M ^a   Korting, H C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Aspartic protease; Candida albicans; Candidosis; HIV protease inhibitor; Oropharyngeal infection

Indexed keywords

ASPARTIC PROTEINASE; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THRUSH;

CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0031774662     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00345.x     Document Type: Article

References (22)

1. Korting, H. C., Ollert, M., Georgii A. & Fröschl, M. (1998) In vitro susceptibility and biotypes of Candida albicans isolates from the oral cavities of patients infected with Human Immunodeficiency Virus. J. Clin. Microbiol. 26, 2626-2631.
2. Samaranayake, L. P. (1992) Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol. 73, 171-180.
3. Fetter, A., Partisani, M., Koenig, H., Kremer, M. & Lang, J. M. (1993) Asymptomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors. J. Oral Pathol. Med. 22, 57-59.
4. Sangeorzan, J. A., Bradley, S. F., He, X., et al. (1994) Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97, 339-346.
5. Chavanet, P., Lopez, J. & Grapin, M. (1994) Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro -in vivo correlations in HIV infected patients. AIDS 8, 945-950.
6. Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K. et al. (1996) Detection and significance of fluconazole resistance in oropharyngeal candidiasis in Human Immunodeficiency virus-infected patients. J. Infect. Dis. 174, 821-827.
7. McCarthy, G. M. (1992) Host factors associated with HIV-related oral candidiasis. Oral Surg. Oral Med. Oral Pathol. 73, 181-186.
8. Gazzard, B. G., Moyle, G. J., Weber, J. et al. (1997) British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 349, 1086-1092.
9. Hoegl, L., Ollert, M. & Korting, H. C. (1996) The role of Candida albicans secreted aspartic proteinase in the development of candidosis. J. Mol. Med. 74, 135-142.
10. Schuffendecker, I., Freydière, A., de Montclos, M. & Gille, Y. (1993) Evaluation of four commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 12, 255-260.
11. Hamilton, J. N., Thompson, S. H., Scheidt, M. J. et al. (1992) Correlation of subclinical candidal colonization of the dorsal tongue surface with the Walter Reed staging scheme for patients infected with HIV-1. Oral Surg. Oral Med. Oral Pathol. 73, 47-51.
12. Hester, C., Hauman, J., Medsci, B. et al. (1993) Oral carriage of Candida in healthy and HIV-infected persons. Oral Surg. Oral Med. Oral Pathol. 76, 570-572.
13. Schmid, J., Odds, F. C., Wiselka, M. J., Nicholson, K. G. & Soll, D. R. (1992) Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients demonstrated by DNA fingerprinting. J. Clin. Microbiol. 30, 935-941.
14. McCullough, M. J., Ross, B. C., Dwyer, B. D. & Reade, P. C. (1994) Genotype and phenotype of oral Candida albicans from patients infected with the Human Immunodeficiency Virus. Microbiology 140, 1195-1202.
15. Boerlin, P., Boerlin-Petzold, K., Goudet, J. et al. (1996) Typing Candida albicans oral isolates from Human Immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting. J. Clin. Microbiol. 34, 1235-1248.
16. DeBernardis, F., Chiani, P., Ciccozzi, M. et al. (1996) Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with Human Immunodeficiency Virus. Infect. Immun. 64, 466-471.
17. Ollert, M., Wende, C., Görlich, M. et al. (1995) Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from Human Immunodeficiency Virus-positive patients. J. Clin. Microbiol. 33, 2543-2549.
18. Ollert, M. W., Söhnchen, R., Korting, H. C., Ollert, U., Bräutigam, S. & Bräutigam, W. (1993) Mechanism of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61, 4560-4568.
19. Borg, M. & Rüchel, R. (1988) Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of the mucosa. Infect. Immun. 56, 626-631.
20. Negi, M., Tsuboi, R. & Ogawa, H. (1984) Isolation and characterization of proteinase from Candida albicans. J. Invest. Dermatol. 83, 32-36.
21. Abad-Zapatero, C., Goldman, R., Muchmore, S. W., Hutchins, C., Stewart, K. & Navaza, J. (1996) Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents. Protein Sci. 5, 640-652.
22. Cutfield, S. M., Dodson, E. J., Anderson, B. F., Moody, P. C. E., Marshall, C. J. & Sullivan, P. A. (1995) The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3, 1261-1271.